OTC · Financial Statements
Forward Pharma A/S (FWPAY) Financial Statements
$300.00
OTC: FWPAY
Market Cap $7.45M
Overview Financials Dividend Forward Pharma A/S most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $1.3B $0 $0 $0 $0 Operating Profit $1.2B $-12.0M $-5.0M $-3.0M $-4.0M Net Profit $917.0M $-9.0M $-4.0M $-6.0M $-2.0M EPS $38845.06 $-368.51 $-177.58 $-268.72 $-77.41 Op Margin 95.0% — — — —
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $111.0M $83.0M $78.0M $80.0M $71.0M Total Liabilities $21.0M $1.0M $1.0M $1.0M $1.0M Cash $110.0M $83.0M $78.0M $79.0M $71.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $940.0M $-15.0M $-2.0M $-6.0M $-2.0M Investing Cash Flow $85.0M $0 $0 $0 $0 Financing Cash Flow $-25.0M $-8.0M $-1.0M $0 $0 Net Cash Flow $52.0M $-27.0M $-5.0M $1.0M $-8.0M Free Cash Flow $940.0M $-15.0M $-2.0M $-6.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 21.67 EV / EBITDA 37.40 FCF Yield -26.86% Quick Ratio 117.44 Interest Coverage 1.95 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock